Clinical-stage biopharmaceutical company Sorrento Therapeutics (NASDAQ:SRNE) has been in the financial press recently, and not necessarily in a good way. In fact, a U.S. Food and Drug Administration (FDA) ruling from August undoubtedly made some SRNE stock holders wriggle in their seats. Source: Shutterstock As it turned out, Sorrento had an unexpected competitor for its
0 Comments
To give you an idea of how vital women CEOs are to environmental, social and governance (ESG) investment strategies, former Bank of England and Bank of Canada governor Mark Carney was appointed in late August as Brookfield Asset Management’s (NYSE:BAM) head of ESG investing. What does this have to do with women as CEOs and
0 Comments
The Koch brothers, Charles and David, became well-known for their libertarian and conservative politics, often portrayed as significant personalities that impact elections and government decisions. However, despite fame as political influencers, their primary activities centered around running Koch Industries Inc., of which they owned over 80%. Koch Industries is a private company that has annual
0 Comments
The fate of past, very promising technologies makes me wary of investing in Kensington Capital (NYSE:KCAC) at this point. The relatively high valuation of Kensington Capital stock and the recent tech sell-off also gives me pause. Source: Tada Images / Shutterstock.com For the uninitiated, those who buy Kensington Capital will eventually own the shares of
0 Comments
Kim Sohee | Getty Images (CNBC Pro subscribers can access the 13D Active-Passive Investor Summit featuring the most influential activist investors by registering here with promo code ”13DCNBC20′ for a 20% discount.) Company: Apartment Investment and Management Co. (AIV) Business: Apartment Investment and Management Co. is a REIT that focuses on the ownership, management, redevelopment, and development
0 Comments
Luckin Coffee (OTCMKTS:LKNCY), the controversial, downtrodden Chinese coffeehouse operator, is finally taking some steps in the right direction, but Luckin stock remains a gamble. Source: Keitma / Shutterstock.com Still reeling from the effects of a revenue-inflating scandal that took Luckin from being a Chinese growth darling to trading over-the-counter, the company recently reappointed Sean Shao,
0 Comments
You can invest in the growing space economy with these ETFs. Procure Space ETF: https://www.zacks.com/funds/etf/UFO/profile?cid=CS-YOUTUBE-FT-VID SPDR S&P Kensho Final Frontiers ETF: https://www.zacks.com/funds/etf/ROKT/profile?cid=CS-YOUTUBE-FT-VID Virgin Galatic: https://www.zacks.com/stock/quote/SPCE?cid=CS-YOUTUBE-FT-VID Maxar Technologies: https://www.zacks.com/stock/quote/SPCE?cid=CS-YOUTUBE-FT-VID Dish Network: https://www.zacks.com/stock/quote/SPCE?cid=CS-YOUTUBE-FT-VID Intelsat: https://www.zacks.com/stock/quote/I?cid=CS-YOUTUBE-FT-VID Northrup Grumann: https://www.zacks.com/stock/quote/NOC?cid=CS-YOUTUBE-FT-VID Lockheed Martin: https://www.zacks.com/stock/quote/LMT?cid=CS-YOUTUBE-FT-VID
0 Comments
Renewed interest in emerging biotechnology companies lifted Sorento Therapeutics (NASDAQ:SRNE) recently. Excessive bearish volumes against the stock could squeeze them out further. If Sorrento continues to post positive news in its drug and testing developments on the novel coronavirus, then SRNE stock may keep rising. Source: Shutterstock At a 34.3% short float, the bearish bet
0 Comments